FDA’s drug repurposing initiative signals renewed focus The FDA announced interest in advancing drug repurposing programs across a wide variety of conditions, though challenges remain. Written byAllison Whitten, PhD

https://www.drugdiscoverynews.com/fda-s-drug-repurposing-initiative-signals-renewed-focus-17247 It’s a well-known fact within drug discovery that most drugs fail. But one failure does not portend a second; old drugs can be repurposed for new indications that work much better with better safety profiles.